Read + Share
Kang S, Zhao S, Wang X, Pan Z, et al. Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for
previously untreated extensive-stage small-cell lung-cancer in China. PLoS One 2025;20:e0328730.
PMID: 40705779
|
 |
|
Kang S, Zhao S, Wang X, Pan Z, et al. Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for
previously untreated extensive-stage small-cell lung-cancer in China. PLoS One 2025;20:e0328730.
PMID: 40705779
|
|
|
|